Nevertheless, our study demonstrates that dual trigger can effectively prevent the severe OHSS and optimize high quality embryo production in high ovarian responders of GnRH-antagonist protocols. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.